Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brooks

Showing results (981-990 of 1,175) with videos related to

Pageof 118
Sort By:
British Journal of Haematology|December 17, 2016
Ublituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trialJeff P Sharman, Charles M Farber, Daruka Mahadevan, et al.
Journal of Applied Clinical Medical Physics|May 29, 2025
Developing reference plans for evaluating global clinical trials credentialing and PSQA systemsFre'Etta M D Brooks, Mohammad Hussein, Jessica Lye, et al.
Journal of Virology|August 8, 2020
Localization of the Interaction Site of Herpes Simplex Virus Glycoprotein D (gD) on the Membrane Fusion Regulator, gH/gLTina M Cairns, Doina Atanasiu, Wan Ting Saw, et al.
BMC Cancer|April 18, 2017
Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patternsMarie K Kirby, Ryne C Ramaker, Brian S Roberts, et al.
Journal of Medicinal Chemistry|February 26, 2000
Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitorsT Kolasa, D E Gunn, P Bhatia, et al.
Journal of Personalized Medicine|September 28, 2021
Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening?Nora Pashayan, Antonis C Antoniou, Andrew Lee, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 2, 2024
Establishing and Characterizing the Molecular Profiles, Cellular Features, and Clinical Utility of a Patient-Derived Xenograft Model Using Benign Prostatic TissuesAlexandra Lapat Polasko, Dalin Zhang, Avanti Ramraj, et al.
Urologic Oncology|September 28, 2021
Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS)Kyla Velaer, I-Chun Thomas, Jaden Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 14, 2022
Evaluating Regional Nodal Irradiation Allocation and Association with Oncologic Outcomes in NSABP B-18, B-27, B-40, and B-41Raymond B Mailhot Vega, Shu Wang, Eric D Brooks, et al.
British Journal of Cancer|October 5, 2023
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotypeMichelle Shen, Shiqin Liu, Angus Toland, et al.
Pageof 118

Showing results (981-990 of 1,175) with videos related to

Sort By:
Pageof 118
British Journal of Haematology|December 17, 2016
Ublituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trialJeff P Sharman, Charles M Farber, Daruka Mahadevan, et al.
Journal of Applied Clinical Medical Physics|May 29, 2025
Developing reference plans for evaluating global clinical trials credentialing and PSQA systemsFre'Etta M D Brooks, Mohammad Hussein, Jessica Lye, et al.
Journal of Virology|August 8, 2020
Localization of the Interaction Site of Herpes Simplex Virus Glycoprotein D (gD) on the Membrane Fusion Regulator, gH/gLTina M Cairns, Doina Atanasiu, Wan Ting Saw, et al.
BMC Cancer|April 18, 2017
Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patternsMarie K Kirby, Ryne C Ramaker, Brian S Roberts, et al.
Journal of Medicinal Chemistry|February 26, 2000
Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitorsT Kolasa, D E Gunn, P Bhatia, et al.
Journal of Personalized Medicine|September 28, 2021
Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening?Nora Pashayan, Antonis C Antoniou, Andrew Lee, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 2, 2024
Establishing and Characterizing the Molecular Profiles, Cellular Features, and Clinical Utility of a Patient-Derived Xenograft Model Using Benign Prostatic TissuesAlexandra Lapat Polasko, Dalin Zhang, Avanti Ramraj, et al.
Urologic Oncology|September 28, 2021
Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS)Kyla Velaer, I-Chun Thomas, Jaden Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 14, 2022
Evaluating Regional Nodal Irradiation Allocation and Association with Oncologic Outcomes in NSABP B-18, B-27, B-40, and B-41Raymond B Mailhot Vega, Shu Wang, Eric D Brooks, et al.
British Journal of Cancer|October 5, 2023
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotypeMichelle Shen, Shiqin Liu, Angus Toland, et al.
Pageof 118